Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-06-11
1998-12-08
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 5142245, 5142302, 514243, 514257, 540496, 540559, 540554, 540548, 540549, 544 9, 544252, 544183, 544184, A61K 3155, A61K 31505, C07D48700, C07D47100
Patent
active
058469699
ABSTRACT:
A sulfonamide derivative or a sulfonic ester derivative represented by the following general formula (I): ##STR1## {G represents an aromatic 5- or 6-membered ring; L represents O or --N(R.sup.1)-- (R.sup.1 represents hydrogen or lower alkyl); and M represents ##STR2## rings A and B represent each an unsaturated 5- or 6-membered ring; Y represents O, S(O).sub.n, C(R.sup.3)(R.sup.4), C(O), N(R.sup.5), CH(R.sup.6)CH(R.sup.7), C(R.sup.8).dbd.C(R.sup.9), N(R.sup.10)C(O), N.dbd.C(R.sup.11), OCH(R.sup.12), S(O).sub.n CH(R.sup.13) or N(R.sup.14)CH(R.sup.15).
REFERENCES:
R.M. Acheson, The Chemistry of Heterocyclic Compounds (1956), Ch.III, V.9:105-147.
G.P. Ellis, The Chemistry of Heterocyclic Compounds (1987), V.9.
G.P. Ellis, The Chemistry of Heterocyclic Compounds (1992), V.47, Part 2.
Capps et al., J. Med. Chem. (1992), V.35:4770-4778.
Boothroyd et al., J. Chem. Soc. (1953), Section 306, Part II, pp. 1504-1509.
Nodiff et al., J. Org. Chem. (1959), V.25:60-65.
Mital et al., J. Chem. Soc. (C) (1969), pp. 2148-2151.
Bendall et al., Aust. J. Chem. (1972), V.25:2451-2465.
Davy et al., Chemistry and Industry (1985), pp. 824-827.
Maller et al., J. of Labelled Compounds and Radiopharmaceuticals, V.XX, No. 12, pp. 1339-1349.
Haneda Toru
Kitoh Kyosuke
Kotake Yoshihiko
Koyanagi Nozomu
Nagasu Takeshi
Eisai Co. Ltd.
Kifle Bruck
Shah Mukund J.
LandOfFree
Tricyclic heterocyclic sulfonamide and sulfonic ester derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic heterocyclic sulfonamide and sulfonic ester derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic heterocyclic sulfonamide and sulfonic ester derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177467